No Data
No Data
Pulmonx Initiated at Buy by Lake Street
Pulmonx Initiated at Buy by Lake Street
Lake Street Initiates Pulmonx(LUNG.US) With Buy Rating, Announces Target Price $12
Lake Street analyst Frank Takkinen initiates coverage on $Pulmonx(LUNG.US)$ with a buy rating, and sets the target price at $12.According to TipRanks data, the analyst has a success rate of 34.2% and
Why We're Not Concerned About Pulmonx Corporation's (NASDAQ:LUNG) Share Price
With a price-to-sales (or "P/S") ratio of 4x Pulmonx Corporation (NASDAQ:LUNG) may be sending bearish signals at the moment, given that almost half of all Medical Equipment companies in the United Sta
Pulmonx(LUNG.US) Officer Sells US$10,312.64 in Common Stock
$Pulmonx(LUNG.US)$ Officer Rose Geoffrey Beran sold 1,184 shares of common stock on May 22, 2024 at an average price of $8.71 for a total value of $10,312.64.Source: Announcement What is statement of
Express News | Pulmonx Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Pulmonx Corporation's Financial Outlook: Single-Product Reliance and Market Penetration Hurdles Threaten Profitability
No Data